We believe that DNA hypermethylation of miR-133a-3p and the miR-133a-3p/MAML1/DNMT3A axis may provide novel therapeutic targets for the treatment of breast cancer, which is also of crucial significance for clinical prevention and diagnosis. The gene discussed is MAML1; the disease is breast cancer.